Becton Dickinson (BDX): Brandes Investment Partners, LP added to its stake +281K shares
Brandes Investment Partners, LP added to its stake in Becton Dickinson, per its Q3 2025 13F.
- 1.15M
- Shares reported · +281K vs prior quarter
- 1.7%
- Disclosed portfolio weight
- $216M
- Reported value
- Holdings as of
- Sep 30, 2025
- Filed
- Nov 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 16, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Sep 26, 2025InsiderOfficer sold ~$10K of BDX shares in the open market
- Oct 9, 2025Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On October 9, 2025, Christopher J. DelOrefice informed Becton, Dickinson and Company (the “Company” or “BD”) of his intention to resign from his position as the Company’s Executive Vice President and Chief Financial Officer effective December 5, 2025 to pursue a new professional opportunity.”
- Oct 27, 2025InsiderOfficer sold ~$11K of BDX shares in the open market
- Oct 31, 2025Layoff notice · 3750 Torrey View Court San Diego CA 92130Layoff notice filed in CA: 59 employees
- Oct 31, 2025Layoff notice · 10020 Pacific Mesa Boulevard San Diego CA 92121Layoff notice filed in CA: 7 employees
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 6, 2025FDARecall: BD InLay Optima Ureteral Stent Kit Size: 6 Fr. x 30 cm, Ureteral Stent Kit REF 788630
- Nov 6, 2025FDARecall: Bard InLay Optima Size: 6 Fr. x 14 cm, Ureteral Stent Kit REF 787614
- Nov 6, 2025FDARecall: BD InLay Optima Ureteral Stent Kit Size: 4.7 Fr. x 26 cm, Ureteral Stent Kit REF 788426
- Nov 7, 2025InsiderDirector sold ~$38K of BDX shares in the open market
What came next
- Nov 17, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 17, 2025, Robert L. Huffines and Jacqueline Wright were elected to the Board of Directors (the “Board”) of Becton, Dickinson and Company (“BD”), effective December 1, 2025.”
- Nov 17, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS. In connection with their appointments to the Board, effective December 1, 2025, Mr. Huffines and Ms. Wright will each receive restricted stock units valued at $33,575, representing a prorated grant from the effective date of their election to the Board through BD’s 2026 Annual Meeting of Shareholders.”
- Nov 20, 2025FDARecall: BD Pyxis MedStation ES, REF: 323, BD Pyxis MedStation ES 7 Drawer Auxiliary, REF: 324, BD Pyxis MedStation ES Tower, REF: 352, BD Pyxis Pro 7-Drawer Auxiliary,…
- Dec 1, 2025InsiderOfficer sold ~$15K of BDX shares in the open market
- Dec 2, 2025FDAFDA device clearance: 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe
- Dec 3, 2025FDARecall: BD Pyxis ES Enterprise Server Catalog Numbers 1115-00, 137672-02,137672-03 137671-02, 137671-03, 137670-02, 137670-03, 139676-01, 139421-01, 139420-01, 139419-…
- Dec 12, 2025FDAFDA device clearance: EnCor EnCompass Breast Biopsy and Tissue Removal System
- Dec 12, 2025FDARecall: Broviac 4.2 Fr Single-Lumen CV Catheter Cutdown Tray with SureCuff Tissue Ingrowth Cuff Cat 60060
- Dec 17, 2025FDARecall: BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso…
- Dec 17, 2025InsiderOfficer sold ~$123K of BDX shares in the open market
- Dec 26, 2025InsiderOfficer sold ~$15K of BDX shares in the open market
- Dec 30, 2025Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit PlansSuspended trading under its employee plans
- Jan 15, 2026Insider · 1 personInsiders: 2 sales (~$334K)
- Jan 26, 2026InsiderOfficer sold ~$15K of BDX shares in the open market
- Jan 27, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On January 27, 2026, the Board of Directors of Becton, Dickinson and Company (“BD”) approved and adopted the BD Executive Severance Plan (the “Severance Plan”), effective January 27, 2026.”
- Jan 27, 2026FDARecall: 10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk non-sterile units per case.
- Jan 30, 2026Company filing · Form 8-K · Unregistered shares, Bylaws or charterSold new shares without registering them, and changed its bylaws, charter or fiscal year
- Jan 30, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 12.8%
- Feb 4, 2026FDAFDA device clearance: UltraScore Focused Force PTA Balloon
- Feb 9, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Becton Dickinson
For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.
How this filing works
Explore the data
Common questions
What does this filing report about Becton Dickinson (BDX) stock?
Brandes Investment Partners, LP added to its stake in Becton Dickinson, per its Q3 2025 13F. Now 1.15M shares, $216M reported value, 1.7% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Sep 30, 2025. Filed: Nov 14, 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Becton Dickinson recently?
For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.
Does this mean BDX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Becton Dickinson
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 4Oct 27, 2026
- SEC Form 144Oct 26, 2026
Everything OQRO holds on this company is on its BDX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
